4.6 Review

Intratumoral microbiome and gastrointestinal cancers

Related references

Note: Only part of the references are listed.
Review Oncology

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments

Sha Li et al.

Summary: Colorectal cancer (CRC) is the third most common and second most fatal cancer, with gut microbiota playing an important role in its initiation and development. Certain bacterial species associated with CRC can cause DNA damage and indirectly promote CRC through host-signaling pathways, while antibacterial drugs have shown potential in inhibiting tumorigenic bacteria.

CANCER BIOLOGY & MEDICINE (2022)

Review Biochemistry & Molecular Biology

Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment

Khiem C. Lam et al.

Summary: This study reveals how the microbiota influences the immune components of the TME to improve cancer therapy. Modulating the microbiota can trigger the IFN-I-NK cell-DC axis within tumors, enhancing the efficacy of immune checkpoint blockade (ICB).
Review Oncology

The gastrointestinal microbiota in colorectal cancer cell migration and invasion

Charlotte Henstra et al.

Summary: Colorectal carcinoma is the third most common cancer in developed countries and the second leading cause of cancer-related mortality. Interest in the influence of intestinal microbiota on CRC has increased rapidly in recent years, with factors such as Fusobacterium nucleatum and Enterococcus faecalis contributing to disease progression by affecting cell-cell adhesion and the extracellular matrix. Understanding how bacterial factors promote CRC recurrence and metastasis is essential for improving patient survival, and further human-based models are needed to study these mechanisms.

CLINICAL & EXPERIMENTAL METASTASIS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Interactions between gastric microbiota and metabolites in gastric cancer

Daofeng Dai et al.

Summary: The study characterized the gastric microbiome and metabolome profiles of GC tumor tissues and non-tumor tissues, revealing higher microbial diversity and richness in tumor tissues, as well as differences in metabolite abundance. Helicobacter and Lactobacillus were found to be associated with the majority of differential metabolites, suggesting their potential roles in GC carcinogenesis and progression.

CELL DEATH & DISEASE (2021)

Article Multidisciplinary Sciences

Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion

Shintaro Okumura et al.

Summary: Research has found that 12 bacterial taxa are enriched in CRC patients, with two Porphyromonas species accelerating CRC onset through butyrate secretion. The invasion of these bacteria in CRC tissues leads to elevated butyrate levels and senescence-associated inflammatory phenotypes.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma

Weixiong Yang et al.

Summary: The study revealed significant differences in the microbiota composition between patients with ESCC and those with PN esophagus, with the former showing reduced microbial diversity and decreased abundances of specific taxa. Functional analysis indicated altered nitrate reductase and nitrite reductase functions in the microbiota of ESCC patients. These findings suggest that specific microbes and microbiota may influence the development of ESCC.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver

Alice Bertocchi et al.

Summary: Bacteria from primary tumors can lead to bacterial dissemination from the intestine to the liver, disrupting the gut vascular barrier, boosting the formation of a premetastatic niche, and enhancing the recruitment of metastatic cells. High levels of PV-1, a marker of impaired gut vascular barrier, are associated with liver bacteria dissemination and metachronous distant metastases in colorectal cancer patients, making it a prognostic marker for distant recurrence and vascular impairment.

CANCER CELL (2021)

Editorial Material Oncology

Intratumoral bacteria generate a new class of therapeutically relevant tumor antigens in melanoma

Gregory D. Sepich-Poore et al.

Summary: The study reveals the potential direct impact of intratumoral bacteria on modulating anti-tumor immune responses by identifying immunogenic bacterial peptides on melanoma cells, and introduces a new class of therapeutically relevant, non-human tumor antigens.

CANCER CELL (2021)

Review Multidisciplinary Sciences

The microbiome and human cancer

Gregory D. Sepich-Poore et al.

Summary: Microbes play significant roles in cancer, and bacteria, viruses, and fungi are believed to be key actors in cancer immunotherapy. Although the number of microbes known to directly cause carcinogenesis is small, further research is needed to understand the causal relationship between microbes and cancer.

SCIENCE (2021)

Review Oncology

Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review

Chengliang Huang et al.

Summary: The study reviewed existing literature and found that gut microbiome has a universal impact on the treatment response and adverse effects of immune checkpoint inhibitors (ICIs) across various solid tumors. Patients with enriched abundance in Firmicutes and Verrucomicrobia generally had better response to ICIs, while those enriched in Proteobacteria had unfavorable outcomes. Moreover, antibiotic use was negatively associated with clinical response to ICIs, especially within 1-2 months prior to treatment initiation. Additionally, a plant-based diet may contribute to the enrichment of gut microbiome favorable to ICIs.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

The role of microbiome in pancreatic cancer

Jenny Jing Li et al.

Summary: Recent studies have revealed the significant impact of the microbiome on cancer development and treatment, especially in pancreatic ductal adenocarcinoma. Utilizing microbiome analyses can lead to the development of new diagnostic and therapeutic strategies, such as fecal microbiota transplantation, probiotics, and dietary changes.

CANCER AND METASTASIS REVIEWS (2021)

Review Oncology

Microbiome and cancer

Nyssa Cullin et al.

Summary: The human microbiome is a complex community that interacts symbiotically with the host across various body sites, impacting physiological processes and disease conditions. While the influence of microbiome communities on cancer development and treatment responsiveness is still being unraveled, understanding these interactions may lead to advancements in precision cancer therapeutics.

CANCER CELL (2021)

Article Chemistry, Multidisciplinary

Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite-Protein Interaction Network

Di Chen et al.

Summary: The authors constructed an integrative MPI network and identified two prognosis-distinctive HCC subtypes based on hub protein expressions. They also observed multiple interdependent features of the poor prognostic subtype such as hypoxia, DNA hypermethylation of metabolic pathways, fatty acid accumulation, immune pathway up-regulation, and exhausted T-cell infiltration. The study suggests potential MPIs linking metabolism to immune regulations in HCC, providing insights for clinical applications surrounding HCC metabolism heterogeneity.

ADVANCED SCIENCE (2021)

Editorial Material Microbiology

mSphere of Influence: the Mycobiota in Human Health and Disease

Soo Chan Lee

MSPHERE (2020)

Article Multidisciplinary Sciences

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

Deborah Nejman et al.

SCIENCE (2020)

Review Biochemistry & Molecular Biology

Microbiota-Derived Metabolites in Tumor Progression and Metastasis

Tania Rossi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Medicine, Research & Experimental

The Mechanism of Bacteroides fragilis Toxin Contributes to Colon Cancer Formation

Wai Teng Cheng et al.

MALAYSIAN JOURNAL OF MEDICAL SCIENCES (2020)

Review Oncology

The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy

Ariel G. Ramirez-Labrada et al.

TRENDS IN CANCER (2020)

Review Gastroenterology & Hepatology

Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma

Jing Lv et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Biochemistry & Molecular Biology

Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes

Erick Riquelme et al.

Article Multidisciplinary Sciences

The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL

Berk Aykut et al.

NATURE (2019)

Article Gastroenterology & Hepatology

Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer

Olabisi Oluwabukola Coker et al.

Review Oncology

Fecal microbiota transplantation in cancer management: Current status and perspectives

Danfeng Chen et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Review Oncology

Harnessing the Microbiome for Pancreatic Cancer Immunotherapy

Gerardo A. Vitiello et al.

TRENDS IN CANCER (2019)

Article Gastroenterology & Hepatology

Mucosal microbiome dysbiosis in gastric carcinogenesis

Olabisi Oluwabukola Coker et al.

Article Multidisciplinary Sciences

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

V. Gopalakrishnan et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Bertrand Routy et al.

SCIENCE (2018)

Article Oncology

The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Vancheswaran Gopalakrishnan et al.

CANCER CELL (2018)

Article Gastroenterology & Hepatology

Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes

Geicho Nakatsu et al.

GASTROENTEROLOGY (2018)

Review Oncology

Gut microbiome modulates efficacy of immune checkpoint inhibitors

Ming Yi et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Article Multidisciplinary Sciences

Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate

Maik Luu et al.

SCIENTIFIC REPORTS (2018)

Article Microbiology

Barrett's esophagus and esophageal cancer: Links to microbes and the microbiome

Teminioluwa A. Ajayi et al.

PLOS PATHOGENS (2018)

Review Gastroenterology & Hepatology

Impact of microbiota in colorectal carcinogenesis: lessons from experimental models

Linda Chia-Hui Yu et al.

INTESTINAL RESEARCH (2018)

Article Multidisciplinary Sciences

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

Susan Bullman et al.

SCIENCE (2017)

Article Gastroenterology & Hepatology

A non-endoscopic device to sample the oesophageal microbiota: a case-control study

Daffolyn R. Fels Elliott et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Oncology

Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human

Lisa Andzinski et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Review Oncology

Commensal bacteria modulate the tumor microenvironment

Theofilos Poutahidis et al.

CANCER LETTERS (2016)

Article Gastroenterology & Hepatology

Bacterial overgrowth and diversification of microbiota in gastric cancer

Lili Wang et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Public, Environmental & Occupational Health

Helicobacter pylori blood biomarker for gastric cancer risk in East Asia

Hui Cai et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)

Article Gastroenterology & Hepatology

Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location

Kosuke Mima et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)

Review Oncology

Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis

Arif Bashir et al.

EUROPEAN JOURNAL OF CANCER PREVENTION (2015)

Article Multidisciplinary Sciences

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Marie Vetizou et al.

SCIENCE (2015)

Article Multidisciplinary Sciences

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Qiang Feng et al.

NATURE COMMUNICATIONS (2015)

Article Multidisciplinary Sciences

Gut mucosal microbiome across stages of colorectal carcinogenesis

Geicho Nakatsu et al.

NATURE COMMUNICATIONS (2015)

Article Multidisciplinary Sciences

Dysbiosis of Fungal Microbiota in the Intestinal Mucosa of Patients with Colorectal Adenomas

Chunguang Luan et al.

SCIENTIFIC REPORTS (2015)

Review Gastroenterology & Hepatology

Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening

Andrea Leung et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)

Review Oncology

Microbiome and Colorectal Carcinoma Insights From Germ-Free and Conventional Animal Models

Helena Tlaskalova-Hogenova et al.

CANCER JOURNAL (2014)

Article Oncology

The Human Gut Microbiome as a Screening Tool for Colorectal Cancer

Joseph P. Zackular et al.

CANCER PREVENTION RESEARCH (2014)

Review Biochemistry & Molecular Biology

Role of the Microbiota in Immunity and Inflammation

Yasmine Belkaid et al.

Article Oncology

Colonization of the Human Gut by E. coli and Colorectal Cancer Risk

Mathilde Bonnet et al.

CLINICAL CANCER RESEARCH (2014)

Review Microbiology

The gut microbiota, bacterial metabolites and colorectal cancer

Petra Louis et al.

NATURE REVIEWS MICROBIOLOGY (2014)

Editorial Material Oncology

The microbiome modulates the tumor macroenvironment

Susan E. Erdman et al.

ONCOIMMUNOLOGY (2014)

Review Public, Environmental & Occupational Health

Epidemiology of Esophageal Cancer in Japan and China

Yingsong Lin et al.

JOURNAL OF EPIDEMIOLOGY (2013)

Article Oncology

Human Gut Microbiome and Risk for Colorectal Cancer

Jiyoung Ahn et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Article Multidisciplinary Sciences

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

Nicholas Arpaia et al.

NATURE (2013)

Article Multidisciplinary Sciences

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

Patrick M. Smith et al.

SCIENCE (2013)

Article Medicine, General & Internal

Helicobacter hepaticus infection in primary hepatocellular carcinoma tissue

Jili Yang et al.

SINGAPORE MEDICAL JOURNAL (2013)

Editorial Material Oncology

Colorectal Cancer: Looking for Answers in the Microbiota

Christian Jobin

CANCER DISCOVERY (2013)

Article Biochemistry & Molecular Biology

Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

Mauro Castellarin et al.

GENOME RESEARCH (2012)

Article Biochemistry & Molecular Biology

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

Aleksandar D. Kostic et al.

GENOME RESEARCH (2012)

Review Multidisciplinary Sciences

Functional interactions between the gut microbiota and host metabolism

Valentina Tremaroli et al.

NATURE (2012)

Article Multidisciplinary Sciences

Structure, function and diversity of the healthy human microbiome

Curtis Huttenhower et al.

NATURE (2012)

Review Multidisciplinary Sciences

Host-Gut Microbiota Metabolic Interactions

Jeremy K. Nicholson et al.

SCIENCE (2012)

Article Gastroenterology & Hepatology

Regulation of p53 Tumor Suppressor by Helicobacter pylori in Gastric Epithelial Cells

Jinxiong Wei et al.

GASTROENTEROLOGY (2010)

Article Microbiology

Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls

Johan Dicksved et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2009)

Review Gastroenterology & Hepatology

Carcinogenesis of Helicobacter pylori

Pelayo Correa et al.

GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma

MP Dore et al.

DIGESTIVE DISEASES AND SCIENCES (2002)